Sichuan Kelun Pharmacy Institute Co., Ltd.

Main research purpose: According to the relevant provisions of bioequivalence test, oxcarbazepine oral suspension (trade name: Trileptin, specification: 60mg/mL) with Novartis Pharma Schweiz AG as the licensee was selected as the reference preparation, and the test preparation oxcarbazepine oral suspension (specification: 60mg/mL) produced by Zhejiang Guojing Pharmaceutical Co., Ltd. and provided by Sichuan Kelun Pharmaceutical Research Institute Co., Ltd. was subjected to human bioequivalence test for fasting and postprandial administration, to compare whether the absorption rate and degree of the drug in the test preparation were within the acceptable range with the reference preparation, and to compare the bioequivalence of the two preparations under fasting and postprandial administration conditions. Secondary research purpose: To observe the safety of the test preparation oxcarbazepine oral suspension (specification: 60mg/mL) and the reference preparation oxcarbazepine oral suspension (trade name: Trileptin, specification: 60mg/mL) in healthy subjects.